UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary tumor location as a prognostic factor in metastatic colorectal cancer

JNCI : Journal of the National Cancer Institute, 2015-03, Vol.107 (3), p.1

2015

Volltextzugriff (PDF)

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

Clinical cancer research, 2019-05, Vol.25 (10), p.2988-2995

2019

Volltextzugriff (PDF)

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment

AIDS (London), 2009-07, Vol.23 (12), p.1547-1556

2009

Volltextzugriff (PDF)

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

The Lancet (British edition), 2006-08, Vol.368 (9534), p.476-482

2006

Volltextzugriff (PDF)

Inference for the Complier-Average Causal Effect From Longitudinal Data Subject to Noncompliance and Missing Data, With Application to a Job Training Assessment for the Unemployed

Journal of the American Statistical Association, 2001-12, Vol.96 (456), p.1232-1244

2001

Volltextzugriff (PDF)

Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2014-05, Vol.121 (5), p.1059-1066

2014

Volltextzugriff (PDF)

Statistical Techniques for Analyzing Data From Prevention Trials: Treatment of No-Shows Using Rubin's Causal Model

Psychological methods, 1998-06, Vol.3 (2), p.147-159

1998

Volltextzugriff (PDF)

Monthly Versus As-Needed Ranibizumab Injections in Patients with Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2014-12, Vol.121 (12), p.2432-2442

2014

Volltextzugriff (PDF)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

The New England journal of medicine, 2021-01, Vol.384 (1), p.20-30

2021

Volltextzugriff (PDF)

Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials

Ophthalmology (Rochester, Minn.), 2014-05, Vol.121 (5), p.1059-1066

2014

Volltextzugriff (PDF)

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions

Ophthalmology (Rochester, Minn.), 2012-04, Vol.119 (4), p.802-809

2012

Volltextzugriff (PDF)

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-term Follow-up in the HORIZON Trial

Ophthalmology (Rochester, Minn.), 2012-04, Vol.119 (4), p.802-809

2012

Volltextzugriff (PDF)

Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263)

AIDS research and human retroviruses, 2009-07, Vol.25 (7), p.665-672

2009

Volltextzugriff (PDF)

Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study

Ophthalmology (Rochester, Minn.), 2014-12, Vol.121 (12), p.2432-2442

2014

Volltextzugriff (PDF)

Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.988-993

2020

Volltextzugriff (PDF)

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema

BMJ open ophthalmology, 2019-10, Vol.4 (1), p.e000335-e000335

2019

Volltextzugriff (PDF)

Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes

Clinical infectious diseases, 1998-05, Vol.26 (5), p.1127-1133

1998

Volltextzugriff (PDF)

Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

Metabolism, clinical and experimental, 2021-03, Vol.116, p.154624, Article 154624

2021

Volltextzugriff (PDF)

Efficacy outcomes with bevacizumab added to chemotherapy (bev+CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.726-726

2018

Volltextzugriff (PDF)

Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population

HIV/AIDS (Auckland), 2011-01, Vol.3 (default), p.1-8

2011

Volltextzugriff (PDF)

Intent-to-Treat Analysis for Longitudinal Studies with Drop-Outs

Biometrics, 1996-12, Vol.52 (4), p.1324-1333

1996

Volltextzugriff (PDF)

MAVERICC, a phase II study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC): Outcomes by tumor location and KRAS status

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3515-3515

2016

Volltextzugriff (PDF)

Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysis

Retina (Philadelphia, Pa.), 2014-11, Vol.34 (11), p.2242-2249

2014

Volltextzugriff (PDF)

MAVERICC, a phase 2 study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV with biomarker stratification as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.493-493

2016

Volltextzugriff (PDF)

A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1-Infected Patients: 48-Week Results of the SHIELD Trial

HIV clinical trials, 2010-10, Vol.11 (5), p.260-269

2010

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Englisch
(180)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Primary tumor location as a prognostic factor in metastatic colorectal cancer

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Inference for the Complier-Average Causal Effect From Longitudinal Data Subject to Noncompliance and Missing Data, With Application to a Job Training Assessment for the Unemployed

Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion

Statistical Techniques for Analyzing Data From Prevention Trials: Treatment of No-Shows Using Rubin's Causal Model

Monthly Versus As-Needed Ranibizumab Injections in Patients with Retinal Vein Occlusion

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-term Follow-up in the HORIZON Trial

Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263)

Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study

Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema

Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes

Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

Efficacy outcomes with bevacizumab added to chemotherapy (bev+CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC)

Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population

Intent-to-Treat Analysis for Longitudinal Studies with Drop-Outs

MAVERICC, a phase II study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC): Outcomes by tumor location and KRAS status

Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysis

MAVERICC, a phase 2 study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV with biomarker stratification as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC)

A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1-Infected Patients: 48-Week Results of the SHIELD Trial

Suchergebnisse filtern